Japan's Toray Develops Nasal Insulin Spray For Diabetes
This article was originally published in PharmAsia News
Executive Summary
Japanese pharmaceutical and textile conglomerate Toray has developed a nasal spray technology to deliver insulin to patients with diabetes. The company uses multiple amino acid peptides and mixes them into insulin. Collaborating with Hoshi Medical School, Toray announced that a preclinical animal test has confirmed that over half of the active ingredient entered the blood stream. Toray is looking for partners to commercialize the technology and plans to enter a clinical trial. (Click here for more - Japanese language